How much funding does DoW Rare Cancers Idea Development Award provide?

The listing does not state a funding amount. Check the funder's announcement for specifics.

When is the deadline for DoW Rare Cancers Idea Development Award?

The deadline is November 18, 2026.

Who is eligible for DoW Rare Cancers Idea Development Award?

Eligible applicants: Open to all applicant types.

DoW Rare Cancers Idea Development Award

Defense Health Agency Contracting Activity - DHACA

Federal

Funding Amount

Not stated

Deadline

November 18, 2026

45 days left

Number of Awards

Grant Type

Federal

Can we apply?

Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.

Eligible organizations

Open to all applicant types

Overview

The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) promotes ideas that are ready for further development and have the potential to yield high-impact findings and new avenues of investigation.

Distinctive Features:

The RCRP encourages applicants to include an exploratory aim or sub-aim to support any necessary discovery-driven research.
Preliminary data with disease-specific rationale are required. However, these data do not necessarily need to originate from studies of the proposed rare cancer type(s)/subtype(s) under study.
Research should have high potential impact on rare cancers and the patient community.